백스사이트 (PCVX)

Natixis Advisors L.P. Acquires Shares of 14035 Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World

Defense World

Truist Financial Corp Boosts Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World

Defense World

Is Vaxcyte Inc (PCVX) a good investment opportunity? – US Post News - US Post News

US Post News

Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Amalgamated Bank - Defense World

Defense World

Natixis Advisors L.P. Invests $881,000 in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

MarketBeat

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update - br.ADVFN.com

br.ADVFN.com

Vaxcyte (NASDAQ:PCVX) Trading 5.5% Higher - MarketBeat

MarketBeat

Vaxcyte Inc (PCVX) Stock: Navigating a Year of Volatility - The InvestChronicle

The InvestChronicle

Wall Street Analysts Think Vaxcyte, Inc. (PCVX) Could Surge 33.33%: Read This Before Placing a Bet - Yahoo News Australia

Yahoo News Australia

Nicholas Investment Partners LP Trims Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

MarketBeat

Keeping an Eye on Vaxcyte Inc (PCVX) After Insider Trading Activity – Knox Daily - Knox Daily

Knox Daily

Q2 2024 EPS Estimates for Vaxcyte, Inc. Lowered by Leerink Partnrs (NASDAQ:PCVX) - MarketBeat

MarketBeat

(PCVX) Investment Report - Stock Traders Daily

Stock Traders Daily

Vaxcyte (NASDAQ:PCVX) Stock Rating Reaffirmed by Needham & Company LLC - Defense World

Defense World

Wall Street Analysts Think Vaxcyte, Inc. (PCVX) Could Surge 33.33%: Read This Before Placing a Bet - Yahoo News Australia

Yahoo News Australia

Wall Street Analysts Think Vaxcyte, Inc. (PCVX) Could Surge 33.33%: Read This Before Placing a Bet - Yahoo News Australia

Yahoo News Australia

Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Simply Wall St

Vaxcyte (NASDAQ:PCVX) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat

MarketBeat

Vaxcyte (NASDAQ:PCVX) Posts Quarterly Earnings Results, Beats Estimates By $0.28 EPS - MarketBeat

MarketBeat

Victory Capital Management Inc. Sells 51542 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World

Defense World

Victory Capital Management Inc. Sells 51,542 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

MarketBeat

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

GlobeNewswire

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

GlobeNewswire

Ready to Jump After Recent Trade: Vaxcyte Inc (PCVX) – Sete News - SETE News

SETE News

Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by New York State Common Retirement Fund - Defense World

Defense World

California Public Employees Retirement System Cuts Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World

Defense World

Vaxcyte COO sells over $184k in company stock - Investing.com Canada

Investing.com Canada

Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells 15000 Shares of Stock - Defense World

Defense World

Vaxcyte CEO sells $928,845 in stock, buys $26,850 worth By Investing.com - Investing.com

Investing.com

(PCVX) Trading Report - Stock Traders Daily

Stock Traders Daily

Insider Selling: Wassil Jim, Vaxcyte Inc [PCVX] CHIEF OPERATING OFFICER divested 3000 shares – Knox Daily - Knox Daily

Knox Daily

Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says

Benzinga

Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says - Vaxcyte (NA - Benzinga

Benzinga

Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst - Seeking Alpha

Seeking Alpha

Vaxcyte CEO sells over $174k in company stock - Investing.com

Investing.com

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire Inc.

Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares - Yahoo Finance

Yahoo Finance

Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday

Benzinga

Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants

GlobeNewswire Inc.

Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal ... - Yahoo Finance

Yahoo Finance

PCVX Stock Quote Price and Forecast - CNN

CNN

Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know

Zacks Investment Research

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte

Zacks Investment Research

Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Yahoo Finance

Yahoo Finance

Why Vaxcyte (PCVX) Might Surprise This Earnings Season

Zacks Investment Research

5 Stocks to Buy That Are Poised to Beat on Earnings This Week

Zacks Investment Research

5 Best Russell 2000 Stocks To Buy According To Hedge Funds - Insider Monkey

Insider Monkey

Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

GlobeNewswire Inc.